US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

295.76

-35.4700-10.71%

Pre-market: 297.501.74+0.59%07:24 EDT

Volume:530.48K

Turnover:162.52M

Market Cap:569.19M

PE:- -

High:323.00

Open:322.79

Low:294.70

Close:331.23

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:1.45

T/O Rate:27.56%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment

Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program

Teva Pharmaceutical Industries (TEVA) Could Be 10% Undervalued After FDA Accepted Ecopipam NDA

Simply Wall St.

Press Release: Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet

YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

Incannex Begins Phase 2 DReAMzz Trial for IHL-42X

Cipla's Pithampur, India Unit Gets 7 Observations From US FDA

MT Newswires Live

Rezolute: Buy Rating Reaffirmed as FDA Catalysts Support CGM‑Driven Upside, Price Target Maintained at $6

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

Regis Healthcare (ASX:REG) Shares Face Valuation Doubts Despite Solid Cash Flow

Simply Wall St.

Analysts’ Opinions Are Mixed on These Real Estate Stocks: Diversified Healthcare Trust (DHC) and Extra Space Storage (EXR)

Is FDA Approval Of TAUKLARIFY Alzheimer’s Tau PET Agent Altering The Investment Case For Lantheus (LNTH)?

Simply Wall St.

Fisher & Paykel Healthcare Investors Back Governance and North America Incentive Plans

Caliway Gets FDA IND Nod for Phase 2 CBL-514 Trial of Abdominal Fat Reduction Drug; Shares Down 4%

MT Newswires Live

Sigma Healthcare sets 2026 AGM date and director nomination deadline

Asian Market Insights: 3 Penny Stocks With Market Caps Over US$100M

Simply Wall St.

Major Insider Move at Aveanna Healthcare Holdings Shakes Up Investor Sentiment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LABU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":295.76,"timestamp":1787947200000,"preClose":331.23,"halted":0,"volume":530479,"hourTrading":{"tag":"盘前","latestPrice":297.5,"preClose":295.76,"latestTime":"07:24 EDT","volume":478,"amount":141814.52180000002,"timestamp":1788175452471,"change":1.74,"changeRate":0.005883,"amplitude":0.032015},"delay":0,"changeRate":-0.10708571083537127,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Pre-Mkt","change":-35.47,"latestTime":"08-31 07:30:31 EDT","open":322.785,"high":323,"low":294.7,"amount":162523074.03118002,"amplitude":0.085439,"askPrice":299.48,"askSize":14,"bidPrice":295.44,"bidSize":3,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":295.76,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.0034,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":297.5,"preClose":295.76,"latestTime":"07:24 EDT","volume":478,"amount":141814.52180000002,"timestamp":1788175452471,"change":1.74,"changeRate":0.005883,"amplitude":0.032015},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":1.445542973311124,"impliedVol":0.9101,"impliedVolPercentile":0.528},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.445542973311124,"shares":1924486,"dividePrice":1.0056,"high":323,"amplitude":0.085439,"preClose":331.23,"low":294.7,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":295.76,"committee":-0.647059,"eps":0,"divideRate":0.0034,"volume":530479,"delay":0,"ttmEps":0,"open":322.785,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":317.2,"twentyDayClose":227.4,"sixtyDayClose":165.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662732058","title":"Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732058?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:55","pubTimestamp":1787662500,"startTime":"0","endTime":"0","summary":"President & CEO, Sabrina Martucci Johnson, discusses the Company's shift to commercial stage, upcoming revenue opportunities, Ovaprene's positive interim Phase 3 results and what could drive value ove","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK4099","NVIB","BK4584","BK4007","BK4555","DARE","03160","GDOC","HYLG","IDNA","LABU","BK4585","BK4604","BK4588","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662433737","title":"Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X","url":"https://stock-news.laohu8.com/highlight/detail?id=2662433737","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662433737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:46","pubTimestamp":1787661960,"startTime":"0","endTime":"0","summary":"First patient dosing represents another major clinical milestone for IHL-42X, building on positive Phase 2 RePOSA results demonstrating reductions in AHI of up to 83% and FDA Fast Track designationNEW","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350465/0/en/incannex-announces-first-patient-dosed-in-dreamzz-phase-2-study-of-ihl-42x.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAG","IE0031619046.USD","MEDX","BK4585","BK4218","IE00B19Z4B17.USD","KBWY","LU2931357623.SGD","PK","PD","IE0009354923.USD","LU0345780281.USD","NVIB","GDOC","LU0345780521.USD","ODD","IE00B66KJ199.SGD","IDNA","BK4157","LU0274383776.USD","RNXT","BK4139","BK4539","BK4588","AEIS","LABU","HYLG","LU0757428866.USD","LU1169589451.USD","LU1815336091.USD","IE00B7SZL793.SGD","BK4181","BK4183","LU2089985449.USD","LU1169590202.USD","BK4017","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732575","title":"Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732575","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732575?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"FDA establishes Investigational New Animal Drug (INAD) File No. 14145, advancing the Company's companion-animal oncology program and marking first milestone under Lupvindol collaborationFORT LAUDERDAL","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350452/0/en/endovia-health-sciences-formerly-splash-beverage-achieves-first-fda-regulatory-milestone-for-cannepil-veterinary-development-program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","LU2324357040.USD","CBD","LABU","LU1201861165.SGD","BK4113","BK4585","LU0130103400.USD","LU0648000940.SGD","THC","LU0963586101.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662581730","title":"Teva Pharmaceutical Industries (TEVA) Could Be 10% Undervalued After FDA Accepted Ecopipam NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662581730","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662581730?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:28","pubTimestamp":1787660886,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) is back in focus after the U.S. Food and Drug Administration accepted its New Drug Application for ecopipam, an investigational pediatric Tourette syndrome treatment with Orphan Drug status.\nSee our latest analysis for Teva Pharmaceutical Industries.\nThe ecopipam news lands after a strong run for Teva Pharmaceutical Industries, with a 30 day share price return of 19.86% and a 1 year total shareholder return of 103.81% that signals building momentum...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/teva-pharmaceutical-industries-teva-could-be-10-undervalued","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/teva-pharmaceutical-industries-teva-could-be-10-undervalued","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4588","BK4557","BK4596","LABU","LU2324357040.USD","TEVA","BK4584","BK4566","LU1983299246.USD","BK4585","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734825","title":"Press Release: Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734825","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734825?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"including the proposed pivotal clinical study strategy for VT-1953;received the FDA's written response on the proposed clinical development. program during the second quarter; is incorporating the FDA's feedback,preparing the appropriate supporting package, and plans to continue its","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBB","LABU","BK4585","BK4007","BK4082","HIND","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662684732","title":"YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2662684732","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662684732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"TAIPEI, Taiwan, Aug.  25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and op","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350403/0/en/yd-bio-announces-peer-reviewed-publication-in-nutrients-co-authored-with-physicians-from-the-taiwan-chronic-disease-healthcare-association-and-the-future-health-institute.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","HCSG","LABU","BK4588","BK4137","BK4585","XBI","LU0128526141.USD","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662348617","title":"Incannex Begins Phase 2 DReAMzz Trial for IHL-42X","url":"https://stock-news.laohu8.com/highlight/detail?id=2662348617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662348617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:55","pubTimestamp":1787658920,"startTime":"0","endTime":"0","summary":"Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) has shared an update. On August 25, 2026, Incannex Healthcare announced that the first patien...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incannex-begins-phase-2-dreamzz-trial-for-ihl-42x?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incannex-begins-phase-2-dreamzz-trial-for-ihl-42x?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","DIVL","BK4585","BK4588","XLV","APIE","CVY","DINT","LABU","SAPH","ARMH","AADR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773981","title":"Cipla's Pithampur, India Unit Gets 7 Observations From US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773981","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773981?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:07","pubTimestamp":1787656033,"startTime":"0","endTime":"0","summary":"Cipla  received seven observations in Form 483 from the U.S. Food and Drug Administration after a follow-up current good manufacturing practices inspection of its manufacturing facility in Pithampur, India.The regulator inspected the Pithampur facility from Aug. 17 to Aug. 25, the pharmaceutical company said in a Tuesday filing with the Indian bourses.Cipla said it will work closely with the U.S. FDA to address the observations within the stipulated timeline.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LABU","MNDmain","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736775","title":"Rezolute: Buy Rating Reaffirmed as FDA Catalysts Support CGM‑Driven Upside, Price Target Maintained at $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736775?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:55","pubTimestamp":1787655352,"startTime":"0","endTime":"0","summary":"In a report released today, Yun Zhong from Wedbush maintained a Buy rating on Rezolute, with a price target of $6.00. Yun Zhong has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reaffirmed-as-fda-catalysts-support-cgmdriven-upside-price-target-maintained-at-6-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reaffirmed-as-fda-catalysts-support-cgmdriven-upside-price-target-maintained-at-6-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736083","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736083?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:50","pubTimestamp":1787655028,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","LU0029874061.USD","XLV","BK4581","GLUE","RYTM","LU0128526141.USD","BK4539","BK4585","LABU","HCSG","BK4137","BK4588","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273574","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273574?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHC), Biogen (BIIB)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689626769.HKD","LU0077335932.USD","XAR","IE00B19Z9P08.USD","XLV","BK4187","BK4082","LU0943347566.SGD","ONC","MDCO","LU0354030438.USD","IE00B894F039.SGD","LU0109394709.USD","LU0868494617.USD","LU1066051498.USD","LU2168564065.EUR","ITA","LU2756315664.SGD","EXI","BK4139","LU2543165471.USD","NATO","GEHC","PPA","LU0689472784.USD","BMED","LU1366192091.USD","BK4526","LU0354030511.USD","PBE","LGHT","MISL","BK4543","LU1551013425.SGD","LU2264538146.SGD","XBI","TRUI","LU1280957306.USD","BIIB","GE","LU1988902786.USD","LU1551013342.USD","LU2168564222.USD","LU0353189763.USD","UXI","LABU","BK4581","BK4588","DFEN","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662518730","title":"Regis Healthcare (ASX:REG) Shares Face Valuation Doubts Despite Solid Cash Flow","url":"https://stock-news.laohu8.com/highlight/detail?id=2662518730","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662518730?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:28","pubTimestamp":1787650099,"startTime":"0","endTime":"0","summary":"Regis Healthcare walked into this result with the stock drifting lower, down about 2% over the past week and roughly 8% over three months, as investors weighed rich P/E multiples against balance sheet concerns. The headline today is simple: the company produced a solid aged care earnings print built on A$1.35b of revenue and A$55m of underlying net profit after tax, supported by A$336m of operating cash flow and a higher fully franked dividend.\nIs Regis Healthcare a mispriced compounder at a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-shares-face-valuation-doubts-despite","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/regis-healthcare-asxreg-shares-face-valuation-doubts-despite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["REG","REG.AU","BK4588","BK4585","BK7113","BK4080","XLV","BK4231","LABU","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662787831","title":"Analysts’ Opinions Are Mixed on These Real Estate Stocks: Diversified Healthcare Trust (DHC) and Extra Space Storage (EXR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662787831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662787831?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:40","pubTimestamp":1787647205,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on Diversified Healthcare Trust (DHC) and Extra Space Storage (EXR)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-real-estate-stocks-diversified-healthcare-trust-dhc-and-extra-space-storage-exr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-real-estate-stocks-diversified-healthcare-trust-dhc-and-extra-space-storage-exr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4084","XLV","BK4588","DHC","BK4581","BK4217","HAUS","LABU","XBI","REZ","BK4203","BK4225","BK4585","INDS","EXR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662780211","title":"Is FDA Approval Of TAUKLARIFY Alzheimer’s Tau PET Agent Altering The Investment Case For Lantheus (LNTH)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780211","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662780211?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:28","pubTimestamp":1787642892,"startTime":"0","endTime":"0","summary":"In August 2026, Lantheus Holdings received U.S. FDA approval for TAUKLARIFY (florquinitau F 18, MK-6240), a PET brain imaging agent to help assess tau neurofibrillary tangle pathology in adults with cognitive impairment being evaluated for Alzheimer’s disease, supported by data from more than 500 subjects across multiple clinical trials.\nThis approval not only broadens Lantheus’s Alzheimer’s imaging portfolio but also reinforces its role as a key partner to pharmaceutical companies...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/is-fda-approval-of-tauklarify-alzheimers-tau-pet-agent-alter","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lnth/lantheus-holdings/news/is-fda-approval-of-tauklarify-alzheimers-tau-pet-agent-alter","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","LNTH","BK4198","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662578510","title":"Fisher & Paykel Healthcare Investors Back Governance and North America Incentive Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2662578510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662578510?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:47","pubTimestamp":1787633235,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) has provided an announcement. Shareholders of Fisher & Paykel Healthcare overwhelmingl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-investors-back-governance-and-north-america-incentive-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-investors-back-governance-and-north-america-incentive-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ISBC","FPH.NZ","XBI","BK4581","LABU","BK4588","BK4211","XLV","BK8004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778308","title":"Caliway Gets FDA IND Nod for Phase 2 CBL-514 Trial of Abdominal Fat Reduction Drug; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778308","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778308?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:19","pubTimestamp":1787631588,"startTime":"0","endTime":"0","summary":"Caliway Biopharmaceuticals Co Ltd  has received approval from the U.S. Food and Drug Administration for an investigational new drug application for a second-phase trial of the combination use of CBL-514 and Zepbound to reduce abdominal subcutaneous fat in overweight or obese adults.The company plans to enroll 120 subjects in the US for Phase 2 of the trial to evaluate the efficacy, safety, and tolerability of the combination use of CBL-514 and tirzepatide, according to a Monday filing to the Taiwan stock exchange.The company's shares were down nearly 4% in Tuesday's trade.This study will evaluate abdominal fat volume change measured by MRI as an efficacy endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","LABU","CBL","BK4588","BK4585","IND","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662783048","title":"Sigma Healthcare sets 2026 AGM date and director nomination deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2662783048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662783048?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:07","pubTimestamp":1787630847,"startTime":"0","endTime":"0","summary":"The latest update is out from Sigma Healthcare Ltd ( ($AU:SIG) ). Sigma Healthcare has scheduled its 2026 Annual General Meeting for 2.00 pm AEDT o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-sets-2026-agm-date-and-director-nomination-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-sets-2026-agm-date-and-director-nomination-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","AGM","LABU","LU0029874061.USD","LU0128526141.USD","BK4195","XLV","BK4585","XBI","BK4229","BK4581","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778578","title":"Asian Market Insights: 3 Penny Stocks With Market Caps Over US$100M","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778578","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778578?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:05","pubTimestamp":1787630744,"startTime":"0","endTime":"0","summary":"As Asian markets navigate a complex landscape marked by economic shifts and global tensions, investors are increasingly seeking opportunities that blend potential with resilience. Penny stocks, often associated with smaller or newer companies, can still offer significant value when backed by strong financials. This article explores three such stocks in Asia, highlighting their robust balance sheets and growth potential as attractive options for those looking to invest in promising...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/retail/hkg-178/sa-sa-international-holdings-shares/news/asian-market-insights-3-penny-stocks-with-market-caps-over-u-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/retail/hkg-178/sa-sa-international-holdings-shares/news/asian-market-insights-3-penny-stocks-with-market-caps-over-u-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","XBI","BK6092","LJ3.SI","01221","BK6098","5WA.SI","XLV","BK1164","BK6511","BK4585","BK6512","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662256200","title":"Major Insider Move at Aveanna Healthcare Holdings Shakes Up Investor Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662256200","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662256200?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:10","pubTimestamp":1787623838,"startTime":"0","endTime":"0","summary":"New insider activity at Aveanna Healthcare Holdings ( ($AVAH) ) has taken place on August 24, 2026. Director Rodney Windley of Aveanna Healthcare H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-aveanna-healthcare-holdings-shakes-up-investor-sentiment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-aveanna-healthcare-holdings-shakes-up-investor-sentiment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","BK4539","BK4581","BK4196","BK4585","XBI","BK4588","AVAH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":9,"totalSize":403,"code":"91000000","status":"200"}]}}